Delivery Order SPE2DB24D1205-SPE2DB25FCVWY

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a medical product used in the treatment of iron deficiency anemia. The contract has a ceiling value of $7,889.01 and a period of performance through April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a pharmaceutical product used for the treatment of iron deficiency anemia. The contract has a firm fixed price and a ceiling value of $2,702.00. It is a non-set-aside contract, indicating open competition. The contract has an ultimate...
This is a $2,170.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a medication used to treat iron deficiency anemia. The contract is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a medical product used for the treatment of iron deficiency anemia. The contract has a ceiling value of $2,398.60 and a period of performance through May 22, 2025. This contract is not designated as a set-aside. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 mL vials of the pharmaceutical product Ferumoxytol, with a ceiling value of $2,434.84 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 17 mL vials of the injectable iron replacement medication ferumoxytol. The $13,498 firm fixed price contract has a period of performance through September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is a significant supplier of medical commodities to the U.S. federal government, including military treatment facilities and other healthcare providers. The...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,619.76, is for the supply of 17 ml vials of the pharmaceutical drug Ferumoxytol. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ1GW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,172,431 units of the pharmaceutical product Ferumoxytol 510 mg/17 ml vial, 17 ml, with a ceiling value of $3,996.92. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.75 firm fixed-price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a period of performance through July 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVWY
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 510 mg/17 ml vials of the drug ferumoxytol, a medication used to treat iron deficiency anemia. The contract has a ceiling value of $5,071.17 and a period of performance through April 16, 2025. It is a firm-fixed price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely one of multiple such orders placed under that larger IDC to fulfill DLA's medical supply requirements, particularly in support of military and veteran healthcare programs.

Generated 7/15/25, 3:35 PM